News
FDA approves new medication for osteoarthritis pain
FDA approval of Zorvolex was based on a double-blind placebo-controlled study which enrolled
FeatureNews
FDA approves Otezla for psoriatic arthritis
The U.S. Food and Drug Administration approved Otezla (apremilast) to treat adults with active
News
Immunossuppressive therapy during pregnancy maybe safe to fetus
Women with chronic autoimmune diseases who take immunosuppressive medications during their
News
Recommendations on calcium intake
In an assessment of the scientific literature, reported as a perspective piece today in the New
News
Updated systemic sclerosis criteria may help in early diagnosis
New classification criteria for systemic sclerosis have just been published and are more
FeatureNews
Fish Oil May Benefit Patients With Early RA
Research published online in Annals of the Rheumatic Diseases suggests that “high-dose fish oil
News
New Injectable for Psoriatic Arthritis Approved by the FDA
The US Food and Drug Administration approved Antares Pharma Inc.’s (ATRS) injectable Otrexup,
News
Ustekinumab Approved for Psoriatic Arthritis
The FDA has approved ustekinumab (Stelara) alone or in combination with methotrexate for adults
News
New Safety Measures
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use
News
New Safety Measures Announced for Extended-release and Long-acting Opiods
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use